WallStreetZenWallStreetZen

NASDAQ: DNTH
Dianthus Therapeutics Inc Stock Ownership - Who owns Dianthus Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Dianthus Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ryan SavitzCFO CBO2025-09-0920,000$8.44
$168.80kBuy
Ryan SavitzCFO CBO2025-09-0920,000$35.00
$700.00kSell

1 of 1

DNTH insiders have bought as... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DNTH insiders and whales buy or sell their stock.

DNTH Shareholders

What type of owners hold Dianthus Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fairmount Funds Management LLC25.39%8,164,219$275.46MInsider
Fmr LLC14.13%4,544,188$153.32MInstitution
Bruce Booth12.80%4,117,125$138.91MInsider
Blake Byers10.38%3,339,137$112.66MInsider
Gv 2016 GP LLC10.38%3,339,137$112.66MInsider
Vestal Point Capital LP9.95%3,200,000$107.97MInstitution
Atlas Venture Fund X LP9.79%3,148,399$106.23MInsider
Third Rock Ventures IV LP9.51%3,058,204$103.18MInsider
Ra Capital Management LP8.91%2,866,733$96.72MInstitution
Lei Meng8.45%2,717,554$91.69MInsider

1 of 3

DNTH vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DNTH53.74%46.26%Net BuyingNet Buying
MDXG46.35%53.65%Net Buying
INVA59.69%40.31%Net SellingNet Selling
MNMD48.27%51.73%Net SellingNet Selling
OCS9.14%0.00%
View Top Biotech Stocks

Dianthus Therapeutics Stock Ownership FAQ

Who owns Dianthus Therapeutics?

Dianthus Therapeutics (NASDAQ: DNTH) is owned by 121.60% institutional shareholders, 104.69% Dianthus Therapeutics insiders, and 0.00% retail investors. Fairmount Funds Management LLC is the largest individual Dianthus Therapeutics shareholder, owning 8.16M shares representing 25.39% of the company. Fairmount Funds Management LLC's Dianthus Therapeutics shares are currently valued at $285.58M.

If you're new to stock investing, here's how to buy Dianthus Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.